• Home
  • Dry AMD
  • Our Science
  • Our Team
  • Our Partners
  • News
  • Contact Us
Skip to content
Skip to content
logo
  • Home
  • Dry AMD
  • Our Science
  • Our Team
  • Our Partners
  • News
  • Contact Us

Initiative

  • Home
  • Initiative
Strategy

Researchers unveil pioneering approach to combat age-related vision loss

June 7, 2024 Cirrus No comments yet

Working together towards common goals strengthens bonds among community members.

Strategy

Replenishing IRAK-M expression in retinal pigment epithelium attenuates outer retinal degeneration

June 5, 2024 Cirrus No comments yet

Chronic inflammation is a constitutive component of many age-related diseases, including age-related macular degeneration (AMD). Here, we identified interleukin-1 receptor–associated kinase M (IRAK…

Search

Categories

  • Strategy (10)

Recent posts

  • Cirrus Therapeutics Announces $11 million Seed Round to Advance Novel Ocular Gene Therapy Designed to Potentially Reverse Crucial Underlying Cause of Dry AMD
  • Exclusive: Gene therapy startup launches with $11M to tackle aging disease of the eye
  • Uveitis in Adults: A Review

Tags

Agenda Community Equality Initiative Social Strength

© 2025 Cirrus Therapeutics. All rights reserved.

  • Privacy Policy
  • Terms of Service